Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...
Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, ...
Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways ...
American Century ETF Trust-Avantis U.S. Small Cap Equity ETF 57.36k Apr 30, 2026 0.18% 345,289 DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Portfolio 55.86k Jan 31, 2026 0.17% 336,259 ...
WX ASOS at DAG (43.3 nm SW from 0O2) 175Phone: 760-254-3630 WX ASOS at NXP (59.6 nm SW from 0O2) Phone: 760-830-8146 WX AWOS-3 at HND (61.9 nm NE from 0O2) Phone: 702-614-4537 WX ASOS at LAS (65.8 nm ...
GlobalAir.com receives its data from NOAA, NWS, FAA and NACO, and Weather Underground. We strive to maintain current and accurate data. However, GlobalAir.com cannot guarantee the data received from ...
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results